EUR 22.9
(0.44%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 736.08 Million EUR | 1.08% |
2022 | 728.22 Million EUR | 5.62% |
2021 | 689.49 Million EUR | 20.14% |
2020 | 573.89 Million EUR | 8.72% |
2019 | 527.86 Million EUR | -2.02% |
2018 | 538.76 Million EUR | 10.7% |
2017 | 486.67 Million EUR | 2.45% |
2016 | 475.01 Million EUR | 11.82% |
2015 | 424.81 Million EUR | 19.27% |
2014 | 356.17 Million EUR | 9.87% |
2013 | 324.17 Million EUR | 25.22% |
2012 | 258.87 Million EUR | 16.84% |
2011 | 221.57 Million EUR | 7.45% |
2010 | 206.2 Million EUR | 2.15% |
2009 | 201.86 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 389.62 Million EUR | 0.0% |
2023 Q4 | 372.41 Million EUR | 0.0% |
2023 FY | 736.08 Million EUR | 1.08% |
2023 Q2 | 363.67 Million EUR | 0.0% |
2022 Q2 | 359.88 Million EUR | 0.0% |
2022 Q4 | 368.34 Million EUR | 0.0% |
2022 FY | 728.22 Million EUR | 5.62% |
2021 Q2 | 338.14 Million EUR | 0.0% |
2021 Q4 | 351.34 Million EUR | 0.0% |
2021 FY | 689.49 Million EUR | 20.14% |
2020 FY | 573.89 Million EUR | 8.72% |
2020 Q2 | 278.29 Million EUR | 0.0% |
2020 Q4 | 295.59 Million EUR | 0.0% |
2019 Q2 | 255.47 Million EUR | 0.0% |
2019 FY | 527.86 Million EUR | -2.02% |
2019 Q4 | 272.38 Million EUR | 0.0% |
2018 Q2 | 260.41 Million EUR | 0.0% |
2018 Q4 | 278.34 Million EUR | 0.0% |
2018 FY | 538.76 Million EUR | 10.7% |
2017 Q2 | 242.24 Million EUR | 0.0% |
2017 FY | 486.67 Million EUR | 2.45% |
2017 Q4 | 244.42 Million EUR | 0.0% |
2016 Q2 | 220.5 Million EUR | 0.0% |
2016 Q4 | 254.51 Million EUR | 0.0% |
2016 FY | 475.01 Million EUR | 11.82% |
2015 Q4 | 202.38 Million EUR | 0.0% |
2015 Q2 | 222.43 Million EUR | 0.0% |
2015 FY | 424.81 Million EUR | 19.27% |
2014 Q2 | 180.48 Million EUR | 0.0% |
2014 Q4 | 175.69 Million EUR | 0.0% |
2014 FY | 356.17 Million EUR | 9.87% |
2013 Q4 | 159.96 Million EUR | 0.0% |
2013 FY | 324.17 Million EUR | 25.22% |
2013 Q2 | 164.2 Million EUR | 0.0% |
2012 Q2 | - EUR | 0.0% |
2012 Q4 | - EUR | 0.0% |
2012 FY | 258.87 Million EUR | 16.84% |
2011 FY | 221.57 Million EUR | 7.45% |
2011 Q4 | - EUR | 0.0% |
2011 Q2 | - EUR | 0.0% |
2010 FY | 206.2 Million EUR | 2.15% |
2010 Q4 | - EUR | 0.0% |
2009 FY | 201.86 Million EUR | 0.0% |
2009 Q4 | - EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Cegedim SA | 615.99 Million EUR | -19.495% |
Guerbet SA | 795.65 Million EUR | 7.487% |
Nexus AG | 241.45 Million EUR | -204.849% |
Bastide Le Confort Médical SA | 529.75 Million EUR | -38.948% |
Revenio Group Oyj | 96.57 Million EUR | -662.182% |
Drägerwerk AG & Co. KGaA | 3.37 Billion EUR | 78.18% |
Sartorius Aktiengesellschaft | 3.39 Billion EUR | 78.323% |
Siemens Healthineers AG | 22.36 Billion EUR | 96.708% |
Medios AG | 1.78 Billion EUR | 58.756% |
Equasens Société anonyme | 219.78 Million EUR | -234.907% |
Stratec SE | 261.91 Million EUR | -181.044% |